期刊文献+

非甾体类抗炎药和幽门螺杆菌与消化性溃疡发病关系的临床分析 被引量:9

Analysis of relationship between helicobacter pylori and non-steroiVdal anti-inflammatory drugs in peptic ulcer
暂未订购
导出
摘要 目的分析非甾体类抗炎药(NSAIDs)、幽门螺杆菌(Hp)与消化性溃疡发病的关系。方法对溃疡组与对照组进行询问服用NSAIDs史,采用快速尿素酶试验检测是否感染Hp。应用病例对照研究的方法,进行统计学处理与分析,采用单因素分析及多因素分析的方法计算病例组和对照组暴露于NSAIDs和Hp这一事件的优势比(OR)来评价发生消化性溃疡的相对危险度。结果①服用NSAIDs的消化性溃疡OR值为2.225;②服用NSAIDs发生消化性溃疡并发上消化道出血的OR值为3.635;③服用NSAIDs发生胃溃疡的OR值为2.537;发生十二指肠溃疡的OR值为1.996;④单纯感染Hp的消化性溃疡患者OR值为6.85,单纯服用NSAIDs的消化性溃疡患者OR值为6.10,既服用NSAIDs,且感染Hp的消化性溃疡患者OR值为13.70。结论①服用NSAIDs发生消化性溃疡的机率较不服用NSAIDs的大;②服用NSAIDs发生消化性溃疡并发上消化道出血的风险高于不服用NSAIDs;③服用NSAIDs发生胃溃疡比发生十二指肠溃疡的机率高;④Hp感染者同时应用NSAIDs增加发生消化性溃疡的危险性。 Objective To analyze the relationship between helicobacter pylori and non - steroidal anti - inflammatory drugs (NSAIDs) in the patients with peptic ulcer. Methods The patients in peptic ulcers group were followed - up and asked whether they took NSAIDs and examined Hp. These two groups' OR value were calculated of the exposed factors (Hp infection and NSAIDs used) to evaluate the risk of peptic ulcer with mono - agent and multi - agent analysis. Results OR value was 2. 225, 3. 635, 2. 537 and 1. 996 in peptic ulcers, in peptic ulcers'complication hemorrhage, in gastric ulcers and in duodenal ulcers who took NSAIDs, respectively. OR value was 6.85 and 6.10 in peptic ulcers were infected by Hp and in peptic ulcers who took NSAIDs, respectively. OR value was 13.70 in peptic ulcers who took NSAIDs and Hp positive. Conclusion There are more risks in patients with peptic ulcers by taking NSAIDs, especially in patients with Hp infection and taking NSAIDs.
出处 《宁夏医学杂志》 CAS 2008年第2期100-102,共3页 Ningxia Medical Journal
关键词 非甾体类抗炎药 幽门螺杆菌 消化性溃疡 Non - steroidal anti - inflammatory drugs ( NSAIDs ) Helicobacter pylori (Hp) Peptic ulcer
  • 相关文献

参考文献3

  • 1Cappell MS, Feng PH, Azuma T, et al. Diagnosis and treatmeat of nonsteroidal an inflammatory drug - associated upper gastrointestinal toxicity [ J ]. Gastroenterol Clin North Am,2000,29:97 - 124.
  • 2顾同进.老年人非甾体抗炎药相关性消化性溃疡病[J].老年医学与保健,2003,9(3):188-189. 被引量:12
  • 3Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth - culture filtrates of Camplyobacter pylori [ J ]. J Med Microbiol,1998,26:93 -99.

二级参考文献11

  • 1Langman M J, Epidemiology evidence on the association between peptic ulceration and antiinflammatory drugs use. Gastroenterology,1989, 96:640 - 646.
  • 2Alvin MG. Clinical gastroenterology in the elderly. Marcel Dekker Inc,1996,54-57.
  • 3Griffin MR. Piper JM, Daugherty JR, et al. NSAID used and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med, 1991, 114: 257-262.
  • 4Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use in peptic ulcer disease: role of non-steroided anti- inflammatory drugs. Ann Intern Med, 1991, 114:735-740.
  • 5Permutt RP, Cello JP. Duodenal ulcer disease in the hospitalized elderly patient.Dig Dis Sci,1982, 27:1 -6.
  • 6Lancaster - Smith MJ, Jadeberg ME, Jackson DA, et al. Ranitidine in the treatment of NSAID associated gastric and duodenal ulcers.Gut, 1991, 32:252-255.
  • 7Walan A, Bader JP, Classen M, et al. Effect of omeperazole and ranitidine on ulcer healing relapse rate in patients with benign gastric ulcer. N Engl J Med, 1989,320:69-75.
  • 8Mamdani M, Rochon PA, Juurlink DN, et al. Observational study of upper gastrointestinal hemorrhage in elderly patients given selective cyclo - oxygenase - 2 inhibitors or conventional non - steroidal anti-inflammatory drugs. BMJ, 2002, 325:624-627.
  • 9Deeks J J, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials. BMJ, 2002, 325: 619-623.
  • 10Bjorkman DJ. Current status of non- steroidal antiinflammatory drug(NSAII)use in the United States:risk factors and frequency of complications.Am J Med, 1999, 107(6A): 3s- 8s.

共引文献11

同被引文献63

引证文献9

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部